Overview
Offers the first focus on Long term care and survivorship regarding mesothelioma patients
Highlight the development of multimodality treatment allowing for more effective and targeted treatment
Encompasses all areas for mesothelioma care, treatment, and research
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (21 chapters)
-
Front Matter
-
Mesothelioma Treatment
-
Front Matter
-
-
Therapeutic Treatments: Chemotherapy, Biotherapy, and Immunotherapy
-
Front Matter
-
-
Supportive Health Care for Treatment
-
Front Matter
-
-
Public Health Impact of Asbestos Worldwide
-
Front Matter
-
Keywords
About this book
Indeed, mesothelioma is a cancer that mainly affects the pleura and peritoneum, usually caused by exposure to asbestos. The number of individuals diagnosed with mesothelioma is increasing world-wide, particularly in developing countries where the use of asbestos remains uncontrolled. In spite of advances in chemotherapy, radiotherapy, and surgical approaches, mesothelioma remains resistant to treatment. According to the International Mesothelioma Interest group, overall survival has not improved; median survival times vary from one month to eighteen months. A small number of patients remain asymptomatic or with minimal symptoms for extended periods, and fewer live three years or more. Mesothelioma is often associated with difficult, intractable symptoms, particularly pain and difficulty breathing. Especially poor prognoses have been reported for those diagnosed with sarcomatoid rather than epithelioid histology, or with advanced disease, poor performance status, or pain and loss of appetite. Despite substantial progress of the last two decades improving the quality of life of patients with cancer, many mesothelioma patients still experience physical, psychological, social, and financial burdens. The development of multimodality treatment and mesothelioma centers has given renewed hope to patients. This book serves as a unique tool for medical professional while providing care for mesothelioma patients.
Editors and Affiliations
About the editors
Mary Hesdorffer received her undergraduate degree at the College of New Rochelle in New York and went on to receive her Masters of Science at the same institution. She is a Nurse Practitioner and spent nearly 20 years actively treating patients with mesothelioma. Ms. Hesdorffer has an expertise in the development and implementation of clinical trials. Her work has been published in peer-reviewed scientific journals and she has lectured both nationally and internationally on the topics pertaining to mesothelioma with particular emphasis on clinical trials as well as symptom and disease management.
Ms. Hesdorffer has been a strong voice in urging increased transparency to the medical and legal issues surrounding mesothelioma with a strong emphasis on ethics. She is passionate in her commitment to the treatment and management of this disease and hopes to increase awareness of the need to advance the science that will lead to a cure. Mary is the Executive Director of the Mesothelioma Applied Research Foundation.
Gleneara E. Bates-Pappas, LMSW, is currently a doctoral candidate at CUNY Graduate Center, an adjunct lecturer at Columbia University School of Social Work, Silberman School of Social Work at Hunter College, New York University Silver School of Social Work and a psychological counselor at CUNY School of Labor and Urban Studies. She received her bachelors degree from the University of Arizona in political science and economics minoring in Africana studies and went on to receive her master, basic science and legal training from Columbia University.
Her doctoral research explores the environmental risk factors for lung cancer mortality among racially ethnic minorities living in New York. Her current research projects aim to elucidate the bio-physiological aspects of tumor resistance in response to chemotherapy and the use of telemedicine to improve quality-of-life and cognitive function in post-treatment cancer survivors. In addition to exploring ways to use virtual and augmented reality to reduce anxiety during treatment in Pediatric oncology patients.
As a cancer researcher, she managed a translational research laboratory at Columbia University Medical Center where she conceptualized and conducted research on heat shock proteins and their role in tumor resistance in response to chemotherapy and the role of platinum agents in inducing checkpoint inhibitors related to tumor progression on the quality of life of patients and their primary caregivers during and post-treatment. In addition, she serves on the American Society of Clinical Oncology Cancer Survivorship Committee and The International Association for the Study of Lung Cancer Smoking Cessation CommitteeBibliographic Information
Book Title: Caring for Patients with Mesothelioma: Principles and Guidelines
Editors: Mary Hesdorffer, Gleneara E. Bates-Pappas
DOI: https://doi.org/10.1007/978-3-319-96244-3
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Nature Switzerland AG 2019
Softcover ISBN: 978-3-319-96243-6Published: 11 June 2019
eBook ISBN: 978-3-319-96244-3Published: 22 May 2019
Edition Number: 1
Number of Pages: X, 239
Number of Illustrations: 8 b/w illustrations, 46 illustrations in colour
Topics: Nursing, Oncology, Pneumology/Respiratory System